Drugs / PF-07225570
last change Sep 2022 re-read 2 minutes ago

PF-07225570

Developed for
urinary bladder cancer
Investigated by
Pfizer

Trials 1 · a red edge is where a trial was stopped

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT05259397 Mar → Sep 2022 urinary bladder cancer Pfizer Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PF-07225570 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05259397